AU Patent

AU2018220022B2 — Trans-sclera portal for delivery of therapeutic agents

Assigned to Johnson and Johnson Surgical Vision Inc · Expires 2019-06-20 · 7y expired

What this patent protects

A portal through the sclera for delivery of an effective amount of therapeutic agent to the back of the eye.

USPTO Abstract

A portal through the sclera for delivery of an effective amount of therapeutic agent to the back of the eye.

Drugs covered by this patent

Patent Metadata

Patent number
AU2018220022B2
Jurisdiction
AU
Classification
—
Expires
2019-06-20
Drug substance claim
No
Drug product claim
No
Assignee
Johnson and Johnson Surgical Vision Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.